PT - JOURNAL ARTICLE AU - S Hyttel-Sorensen AU - A Pellicer AU - T Alderliesten AU - T Austin AU - F van Bel AU - M Benders AU - O Claris AU - E Dempsey AU - AR Franz AU - M Fumagalli AU - C Gluud AU - B Grevstad AU - C Hagmann AU - P Lemmers AU - W van Oeveren AU - G Pichler AU - AM Plomgaard AU - J Riera AU - L Sanchez AU - P Winkel AU - M Wolf AU - G Greisen TI - O-221 Safeboosc – A Phase Ii Randomised Clinical Trial On Cerebral Near-infrared Spectroscopy Oximetry In Extremely Preterm Infants AID - 10.1136/archdischild-2014-307384.291 DP - 2014 Oct 01 TA - Archives of Disease in Childhood PG - A109--A110 VI - 99 IP - Suppl 2 4099 - http://adc.bmj.com/content/99/Suppl_2/A109.2.short 4100 - http://adc.bmj.com/content/99/Suppl_2/A109.2.full SO - Arch Dis Child2014 Oct 01; 99 AB - Background and aims Extremely preterm infants have a high risk of moderate to severe long-term neurodevelopmental impairment. Hypoxic or hyperoxic brain injury may be a contributing factor. The SafeBoosC trial investigated if it is possible to stabilise the cerebral oxygenation of extremely preterm infants. Methods This was a phase II randomised, single blinded, clinical trial. Infants born before 28 weeks of gestation were eligible. Within 3 h of birth, infants were randomly assigned to either cerebral near infrared spectroscopy (NIRS) oxygenation monitoring in combination with a treatment guideline (experimental) or blinded NIRS monitoring with standard care (control). The primary outcome was the area under the curve of the time series of absolute deviation from the cerebral oxygenation target range of 55% to 85%, expressed in % hours (the burden of hypoxia and hyperoxia). We hypothesised that there would be more than 50% reduction in this burden in the experimental group. Results 166 infants with a median postmenstrual age of 26.4 weeks were enrolled (Table 1). Two infants were withdrawn. 86 infants randomised to the NIRS group had a median burden of hypoxia and hyperoxia of 36.1% hours (IQR 9.2 to 79.5) compared with 81.3% hours (IQR 38.5 to 181.3) in the control group (Figure 1), a reduction of 58% (95% CI 35% to 73%) (p= <0.0001). We found no other statistically significant differences between the two groups to term corrected age. Conclusions Cerebral oxygenation was stabilised using a treatment guideline in combination with cerebral NIRS monitoring in extremely preterm infants. View this table:Abstract O-221 Table 1